ghk cu heart health GHK-CU Peptide Therapy GHK-Cu (Copper Peptide) - LeadWest

"PC4 coactivates MyoD by relieving the histone deacetylase 4-mediated inhibition of myocyte enhancer factor 2C"

J., Alatzoglou, K

the copper complex (GHK-Cu) weighs approximately 401 Da

This mechanism is linked to healthier cellular aging and regeneration

User experimentation suggests that longer initial treatment periods (6+ months continuous) support better benefit retention during subsequent breaks, complete discontinuation breaks of 1-2 months show acceptable benefit maintenance for most users, and very extended breaks (3-6+ months) increase risk of regression toward pre-treatment baseline particularly for short initial treatment courses